A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: A case-control study

Journal of Viral Hepatitis

Volumn 18, Issue 7, 2011, Pages

  Akkaz, H ^a   Bayram, S ^a,b   Bekar, A ^a   Akgollu E ^a   Ulger Y ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

Author keywords

hepatocellular carcinoma; microRNA; miR 196a 2; rs11614913 polymorphism; susceptibility

Indexed keywords

MICRORNA; MICRORNA 196 A 2; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HOMOZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TURKEY;

EID: 79959584465     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01414.x     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Farazi PA, DePinho RA,. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687. (Pubitemid 44286000)
3. El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576. (Pubitemid 46890874)
4. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
5. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with role in cancer. Nat Rev Cancer 2006; 6: 259-269.
6. Bartel B,. MicroRNAs directing siRNA biogenesis. Nat Struct Mol Biol 2005; 12: 569-571. (Pubitemid 40980804)
7. Vasudevan S, Tong Y, Steitz JA,. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318: 1931-1934.
8. Ryan BM, Robles AI, Harris CC,. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
9. Akkäz H, Bayram S, Bekar A, Akgöllü E, Ozdil B,. Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma. J Viral Hepat 2010; 17: 668-674.
10. Akkäz H, Bayram S, Bekar A, Akgöllü E, Ozdil B,. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 2010; 34: 298-302.
11. Ludwig JA, Weinstein JN,. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005; 5: 845-856. (Pubitemid 41746029)
12. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070. (Pubitemid 41161233)
13. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-1908. (Pubitemid 46707844)
14. Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequences and non small cell lung cancer survival. J Clin Invest 2008; 118: 2600-2608. (Pubitemid 351949787)
15. Duan R, Pak C, Jin P,. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16: 1124-1131. (Pubitemid 47062732)
16. Hoffman AE, Zheng T, Yi C, et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 2009; 69: 5970-5977.
17. Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 2010; 71: 621-626.
18. Tian T, Shu Y, Chen J, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18: 1183-1187.
19. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q,. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 2010; 55: 2288-2293.
20. Christensen BC, Avissar-Whiting M, Ouellet LG, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010; 16: 3713-3720.
21. Srivastava K, Srivastava A, Mittal B,. Common Genetic Variants in Pre-MicroRNAs and Risk of Gallbladder Cancer in North Indian Population. J Hum Genet 2010; 55: 495-499.
22. Dou T, Wu Q, Chen X, et al. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 2010; 136: 1853-1859.
23. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430. (Pubitemid 32844200)
24. Tsai JF, Chang WY, Jeng JE, et al. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994; 14: 98-102.
25. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973; 60: 646-649.
26. Bond GL, Levine AJ,. A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene 2007; 26: 1317-1323. (Pubitemid 46328460)
27. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124. (Pubitemid 47056470)
28. Gao LB, Bai P, Pan XM, et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2011; 125: 571-574.
29. Yekta S, Shih IH, Bartel DP,. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304: 594-596. (Pubitemid 38541919)
30. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-6678.
31. Wynter CV,. The dialectics of cancer: a theory of the initiation and development of cancer through errors in RNAi. Med Hypotheses 2006; 66: 612-635. (Pubitemid 43060182)
32. Kanai M, Hamada J, Takada M, et al. Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas. Oncol Rep 2010; 23: 843-851.
33. Masaki T, Tokuda M, Ohnishi M, et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24: 72-81. (Pubitemid 26249416)
34. Dai Z, Liu YK, Cui JF, et al. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics 2006; 6: 5857-5867. (Pubitemid 44764022)
35. Schimanski CC, Frerichs K, Rahman F, et al. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol 2009; 15: 2089-2096.